Vanguard Group Inc Amphastar Pharmaceuticals, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$298 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$97.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$84.7 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$81.3 Million0.05% of portfolio
-
State Street Corp Boston, MA1.53MShares$76.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.46B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...